Skip to main content
  • Accessibility
  • Headlines
  • Coronavirus-News
  • Get-Hooked
  • Technology
  • Education
  • Employment
  • Parasports
  • Ask Bhavna
  • NHBrandView
  • Independent Living
  • Lifestyle
  • NH Videos
×
Newz Hook – Changing Attitudes towards Disability Logo
  • Stories
  • Videos
  • Inclusive
  • NH Voice
  • Login
COVID-19 Notification by Government in Accessible Format

Accessibility Tools

Text Size:

Contrast Scheme:

  • C
  • C

Reset

  • Home
  • Headlines
  • Clinical trials in India’s first COVID-19 vaccine to start next week

Clinical trials in India’s first COVID-19 vaccine to start next week

Image of a person's hand with an iinjection being given
Headlines July 8, 2020
  • Click to share on Twitter (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on WhatsApp (Opens in new window)

Over 1,100 people are expected to enrol in the first two phases of human clinical trials for COVAXIN, which is India’s first COVID-19 vaccine. This is according to vaccine developers Bharat Biotech. The Phase I clinical trials are scheduled to start next week and 13 July is set as the date for participant enrolment.

Results from Phase I will decide the start of the next phase of testing. The Indian Council for Medical Research (ICMR)) has selected 12 institutes to conduct these trials, including the All India Institute of Medical Sciences (AIIMS) in Delhi and Patna. These will be fast-tracked.

375 participants will take part in Phase I. They will be split into three groups of 125 and be given two doses – one each of the candidate and control vaccine – 14 days apart. Pending satisfactory completion of Phase I, a further 750 participants will be registered for Phase II of the clinical trials.

According to the application made by Hyderabad-based Bharat Biotech, the timeframe for Phase I is 28 days, which means the trial must start by 18 July to meet the government’s promise of releasing a vaccine by 15 August.
It is unclear, however, if a COVID-19 vaccine can be released after finishing just one of three trial phases.

Two of the world’s leading vaccine candidates – AZD1222 (British firm AstraZeneca) and MRNA-1273 (US-based Moderna) – have been cleared for Phase II, III trials. Across the world over 1.14 crore COVID-19 cases have been reported, including 5.34 lakh deaths. India is now the third worst-affected country, with over seven lakh infections.

Watch in Sign Language

Support us to make NewzHook Sustainable – Make a Contribution Today

We need your continued support to enable us work towards Changing Attitudes towards Disability. Help us in our attempt to share the voices of people with disabilities that enable them to participate in the society on an equal footing!

Contribute to Newz Hook

NH Videos

Healing pain through art - Dr. Anubha Mahajan, Founder Chronic Pain India

Contribue to Newz Hook |Disability news. Support us to make NewzHook Sustainable – Make a Contribution Today.

Newsletter

 Subscribe to our Newsletter

Want to feature disability stories or share disability news with the disabled community? Write to:

editor@newzhook.com

Newz Hook - Accessible News

Download App Now!

Videos

View More

Get-hooked

Understanding Art Therapy For Autism

Get-hooked

Understanding Inborn Errors of Metabolism

Get-hooked

#AllYouNeedIsLove- Shivprasad & Sharmila’s marriage is a bond of love & friendship

Get-hooked

#DisabilityInfluencers- Preetha Thonnakkal uses social media to raise awareness about the disabled community

Newz Hook Logo

About Newz Hook

Newz Hook | Disability News - media site focusing on Disability Stories and Changing Attitudes towards Disability globally. We highlight disability news, offer inclusive solutions and create accessible collaborations. Our focus is to have Inclusion Champions from across the globe who will share disability stories and news.
Lets come together to change attitudes towards disability!

Newz Hook is reader-supported. When you buy through links on our site, we may earn an affiliate commission.

Follow us on:

Related Links

  • About Us
  • Contact Us
  • Privacy Policy
  • Partner with Newz Hook
  • Embed Newz Hook Timeline
  • Affiliate disclosure
  • Accessibility Statement
  • Contribute to Newz Hook

Our Awards

Zero Project Award Winner 2018
Back To Top
© 2019 All Right Reserved. Inclusive News India Private Limited.

Ask Bhavna

All fields are mandatory unless specified as optional.